AlphaCrest Capital Management’s AtriCure ATRC Stock Holding History

AlphaCrest Capital Management’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-19,752	Closed	-$772K	–	100
2022 Q3	$772K	Buy	+19,752	New	+$904K	0.05%	766
2022 Q2	–	Sell	-5,219	Closed	-$343K	–	1247
2022 Q1	$343K	Buy	+5,219	New	+$338K	0.02%	1062
2021 Q4	–	Sell	-3,607	Closed	-$251K	–	1365
2021 Q3	$251K	Buy	+3,607	New	+$278K	0.01%	1156
2021 Q1	–	Sell	-14,900	Closed	-$829K	–	1179
2020 Q4	$829K	Buy	14,900 +5,393	+57%	+$233K	0.07%	390
2020 Q3	$379K	Buy	+9,507	New	+$403K	0.04%	739

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

AlphaCrest Capital Management's ATRC Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of AtriCure (ATRC) in Q4 2022, closing a stake of 19,752 shares — an estimated $772K sold.

AlphaCrest Capital Management first reported a position in ATRC in Q3 2020 and held it in 5 quarters. The position peaked at $829K in Q4 2020. 211 funds tracked by Wall St. Rank hold ATRC as of Q4 2022.

AlphaCrest Capital Management reported no remaining AtriCure position as of Q4 2022 after selling out during the quarter.
AlphaCrest Capital Management sold 19,752 AtriCure shares in Q4 2022, an estimated $772K.
AlphaCrest Capital Management first reported a position in AtriCure in Q3 2020 and held it in 5 quarters.
AlphaCrest Capital Management's AtriCure position peaked at $829K in Q4 2020.
211 funds tracked by Wall St. Rank held AtriCure as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.